Based on the TCGA cohort, we integrated clinical factors such as age, stage, N stage, SPCS1, IGFBP1 and TSPYL2 to construct a nomogram to enhance survival prediction for patients with stomach cancer (Figure 12C). This evidence concerns the gene IGFBP1 and gastric neoplasm.